Viewing StudyNCT06340334



Ignite Creation Date: 2024-05-06 @ 8:20 PM
Last Modification Date: 2024-10-26 @ 3:25 PM
Study NCT ID: NCT06340334
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-04-01
First Post: 2024-03-25

Brief Title: Efficacy and Safety of Tegoprazan Dual Therapy and Furazolidone-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication A Prospective Multicenter Open-label Randomized Controlled Clinical Study
Sponsor: Nanjing First Hospital Nanjing Medical University
Organization: Nanjing First Hospital Nanjing Medical University

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-03
Start Date Type: ESTIMATED
Primary Completion Date: 2024-12-31
Primary Completion Date Type: ESTIMATED
Completion Date: 2024-12-31
Completion Date Type: ESTIMATED
First Submit Date: 2024-03-25
First Submit QC Date: March 25 2024
Study First Post Date: 2024-04-01
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-03-25
Last Update Post Date: 2024-04-01
Last Update Post Date Type: ACTUAL